🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I don’t wanna jinx it, but it’s looking like perfect weather for JP Morgan #JPM2025 First time in many years of no rain? ☀️

Stunning day in San Francisco today! Having a zen day before JP Morgan. (And nice escape from the northeast tundra!) Happy #JPM25

Excited to be in San Francisco this week. I'll be giving a corporate presentation for Azitra at Biotech Showcase this afternoon at 3p PT. $AZTR ir.azitrainc.com/news-releases/…

Taking a driverless car in San Francisco. I was skeptical, but these are actually SO cool! Waymo

The US decision to withdraw from the WHO undermines global health cooperation. The World Health Organization (WHO) Council on the Economics of #HealthForAll (WHO Council on the Economics of Health For All), which I co-chaired, underlined why collective investment in #HealthForAll is critical for people and economies. The evidence is

Remember the headlines last fall saying to throw out black spatulas? Turns out the authors of the study miscaulated the EPA's exposure guidelines by an order of magntitude (42k ng/day vs. 420k ng/day). Soo it's probably fine :) sciencedirect.com/science/articl…

The entire public health/biopharma sector has been disrupted. Some personal anecdotes/impacts - Previous job offers rescinded - Travel plans for the year cancelled - Grants essentially frozen - No disease surveillance comms - No more diversity for agencies OR clinical trials (??)

Ice on the Hudson 🥶 ❄️

I submitted an AHRQ grant last month with a review scheduled next week Reached out to PO to see if it’s still meeting. Email returned; no longer works there Reached out to other contact; study section cancelled Scientific progress across the board is being unilaterally halted.

This is a great graphic! I’ve been looking for something like this. I can never seem to keep track of who sold which consumer division to whom.

I've admittedly often complained about high indirect costs on my grants (my worst offender was Jackson Labs at 90%), but indirect costs are critical in supporting fundamental academic research. Here's a great infographic showing where these funds go:

I’ll be giving at talk at 3:45p ET today at the BIO CEO & Investor conference $AZTR ir.azitrainc.com/news-releases/…

It's rare disease month, and I thoroughly enjoyed joining Kira Dineen, MS, LCGC, CG(ASCP)CM at BIO CEO this week on her podcast DNA Today: A Genetics Podcast to talk about our engineered skin commensal platform at Azitra to treat rare skin diseases. 🧬 dnapodcast.com/episodes/2025/…

After years of working full time and getting a PhD part time at UCL Institute for Innovation and Public Purpose, I passed my PhD defense today! Huge thank you Mariana Mazzucato for all the guidance over the years and my wonderful examiners Cecilia Rikap Suerie Moon!!

Kira Dineen, MS, LCGC, CG(ASCP)CM DNA Today: A Genetics Podcast Travis Whitfill More from Azitra, Inc.'s Travis Whitfill on the DNA Today: A Genetics Podcast - What led you to Co-Found Azitra? What need did you see? The potential of targeting the skin w/ synthetic biology methods & huge unmet need in a variety of severe, under addressed derm indications podbean.com/ep/pb-iv36f-17…

Looking forward to presenting next week at the Microbiome Times Forum in Brussels! Azitra, Inc. $AZTR ir.azitrainc.com/news-releases/…

It was an honor being on RARECast this week. Thanks Daniel Levine for having me! open.spotify.com/episode/5jWlSF…

.Travis Whitfill Azitra, Inc. , discusses Netherton syndrome, the company’s platform technology for engineering live biotherapeutic products, and why it takes more than simply inserting a gene into a desired bacteria to produce these treatments. globalgenes.org/raredaily/engi…

Check out Azitra, Inc.'s Travis Whitfill on the #RARECast #podcast - Engineering Skin Bacteria to Be Live Biotherapeutics - digging in on #NethertonSyndrome Levine Media Group #precisionderm #dermatology podcasts.apple.com/us/podcast/eng…